Table 1.
Baseline parameter | Blood parameter | Neurological assessment | NCSf Parameter | Subjective Score | |
---|---|---|---|---|---|
Week 0 | Age Gender Weight Size Comorbidity Medication Duration of disease (Diabetes and DPN) |
HbA1ca | Clinical examination NSS NDSc |
Bilateral amplitudes and NCVbof nn. surales and tibiales | NRSd |
Week 6 | Clinical examination NSSe NDS |
Bilateral amplitudes and NCV of nn. surales and tibiales | NRS | ||
Week 15 | Change of medication | HbA1c | Clinical examination NSS NDS |
Bilateral amplitudes and NCV of nn. surales and tibiales | NRS Adverse events |
Weekly (treatment 1–10) | Change of medication | NRS Adverse events |
aHbA1c= glycated hemoglobin; bNCV = nerve conduction velocity; cNDS = neuropathy deficit score; dNRS = numeric rating scale; eNSS = neuropathy symptom score; fNCS = nerve conduction studies